Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 3 of 6

Dr Ian Hudson, chief executive of the Medicines Healthcare and Product Regulatory Agency (MHRA) says: 'We are still considering two main models for the post-Brexit regulation of medicines'

Dr Ian Hudson, chief executive of the Medicines Healthcare and Product Regulatory Agency, says the agency is preparing for two scenarios: one of continued partnership with the EMA; the other leaving the MHRA cut off from European procedures

Source  Courtesy of MHRA